Research Output per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 23 Similar Profiles
Graft vs Host Disease
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Transplantation
Medicine & Life Sciences
Fetal Blood
Medicine & Life Sciences
Transplants
Medicine & Life Sciences
Bone Marrow
Medicine & Life Sciences
Tissue Donors
Medicine & Life Sciences
Angiogenesis Inducing Agents
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Infectious Events in Pregnancy: PlGF Contributes to Maternal Morbidity
Project: Research project
Research Output 2010 2019
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
Lachowiez, C., Cook, R. J., Hayes-Lattin, B., Maziarz, R., Borate, U., Traer, E., Leonard, J., Newell, L., Dao, K-H. & Meyers, G., Jan 1 2019, In : Hematology/ Oncology and Stem Cell Therapy.Research output: Contribution to journal › Article
Open Access
Myelodysplastic Syndromes
Homologous Transplantation
Acute Myeloid Leukemia
Hematopoietic Stem Cell Transplantation
Transplantation
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias
Lin, T. L., Newell, L., Stuart, R. K., Michaelis, L. C., Rubenstein, E., Pentikis, H. S., Callahan, T., Alvarez, D., Liboiron, B. D., Mayer, L. D., Wang, Q., Banerjee, K. & Louie, A. C., Jan 1 2019, In : Cancer Chemotherapy and Pharmacology.Research output: Contribution to journal › Article
Open Access
Pharmacodynamics
Daunorubicin
Pharmacokinetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors
Newell, L., SHOOP, KELSEA. M., KNIGHT, REBEKAH. J., MURRAY, SARA. N., KWOCK, ROGELYN. P., JACOBY, CAROL. E., Slater, S., ALLEN, BRYON. E., OTTOWA, CASONDRA., COTA, B. R. A. D., APPEL, PEGGY. L., COOK, RACHEL. J., Maziarz, R. & Meyers, G., Jan 1 2019, In : Cytotherapy.Research output: Contribution to journal › Article
Granulocyte Colony-Stimulating Factor
Siblings
Blood Cells
Stem Cells
Tissue Donors
1
Citation
(Scopus)
Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802
Holtan, S. G., DeFor, T. E., Panoskaltsis-Mortari, A., Khera, N., Levine, J. E., Flowers, M. E. D., Lee, S. J., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Cutler, C. S., Arai, S., Lazaryan, A., Newell, L., Jagasia, M. H., Pusic, I., Wood, W. A., Renteria, A. S. & 17 others, Aug 14 2018, In : Blood advances. 2, 15, p. 1882-1888 7 p.Research output: Contribution to journal › Article
Graft vs Host Disease
Survival
Mortality
Intestinal Mucosa
trans-crotonin
61
Citations
(Scopus)
Cpx-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia
Lancet, J. E., Uy, G. L., Cortes, J. E., Newell, L., Lin, T. L., Ritchie, E. K., Stuart, R. K., Strickland, S. A., Hogge, D., Solomon, S. R., Stone, R. M., Bixby, D. L., Kolitz, J. E., Schiller, G. J., Wieduwilt, M. J., Ryan, D. H., Hoering, A., Banerjee, K., Chiarella, M., Louie, A. C. & 1 others, Sep 10 2018, In : Journal of Clinical Oncology. 36, 26, p. 2684-2692 9 p.Research output: Contribution to journal › Article
Daunorubicin
Cytarabine
Acute Myeloid Leukemia
Liposomes
Injections